Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Merck KGaA : Effect Pigments for Architecture: Merck Exhibits at the Middle East Coatings Show 2012

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/05/2012 | 10:24am CET

Darmstadt/Germany, March 5, 2012 - Merck will be presenting its effect pigments for architecture at the Middle East Coatings Show in Dubai from March 12 to 14, 2012. This exhibition is the most important platform for the coatings sector in the Middle East and the Gulf region. The focus of the exhibition will be on architectural applications, which have been seeing rapid growth in the region for the past several years. The trend toward gold and silver shades, which can currently be seen in lifestyle products and interior designs, is also being reflected in architecture.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MERCK KGAA
12/08 MERCK : Chelmsford High School Students explore life sciences careers
12/08 BIOCARTIS GROUP NV : Biocartis launches second liquid biopsy assay - Assay co-de..
12/06 MERCK : Consumer Health business drives consumer-centric, purposeful innovation
12/06 MERCK : s Consumer Health Business Drives Consumer-Centric, Purposeful Innovatio..
12/05 RONASTAR® RED ALLURE : The elegant, matte pigment innovation from Merck
12/05 MERCK : to Provide Provantage® End-to-End Services to Acticor Biotech SAS
12/02 MERCK : Launches Parteck® MXP Excipient for Increased Solubility
12/01 MERCK : Expands Distribution Agreement with Roche
12/01 QuintilesIMS Forms New Collaboration with Bristol-Myers Squibb, Lilly, Merck ..
12/01 DGAP-PVR : Merck KGaA: Release according to Article 26, Section 1 of the WpHG w..
More news
Sector news : Specialty & Advanced Pharmaceuticals
12/08 BRISTOL MYERS SQUIBB : Meyers Squibb to pay $19.5 million to settle off-label pr..
12/07 MYLAN : EpiPen maker Mylan to restructure, cut workforce
12/07DJABBOTT LABORATORIES : Seeks to Terminate Alere Deal -- Update
12/07DJPFIZER : Fined $107 Million for Overcharging U.K. for Epilepsy Drug
12/07DJABBOTT LABORATORIES : Seeks to Terminate Alere Deal
More sector news : Specialty & Advanced Pharmaceuticals
News from SeekingAlpha
12/01 Roche expands distribution partnership with Merck KGaA
11/30 Evotec and Merck KGaA team up to discover new therapeutic targets
11/29 FDA accepts avelumab BLA under Priority Review for rare type of skin cancer
11/22 QuintilesIMS forms collaboration with major drug firms to better understand r..
11/15 Merck KGaA 2016 Q3 - Results - Earnings Call Slides
Advertisement
Financials (€)
Sales 2016 15 095 M
EBIT 2016 3 561 M
Net income 2016 1 782 M
Debt 2016 11 024 M
Yield 2016 1,37%
P/E ratio 2016 21,66
P/E ratio 2017 20,49
EV / Sales 2016 1,52x
EV / Sales 2017 1,35x
Capitalization 11 883 M
More Financials
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 107 €
Spread / Average Target 16%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stefan Oschmann Chief Executive Officer
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Crocifissa Attardo Member-Supervisory Board
Mechthild Auge Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA2.65%12 822
ABBVIE INC4.02%97 490
KYOWA HAKKO KIRIN CO L..-20.26%7 799
JAZZ PHARMACEUTICALS P..-28.43%6 025
MALLINCKRODT PLC-28.02%5 437
ZHANGZHOU PIENTZEHUANG..1.31%4 087
More Results